/Companies

RNA Connect

1 known investors

Find your way into RNA Connect

Each arrow is one introduction. Sign up to fill in the first one.

380 people can intro you to Anna

Ask Akiko Iwasaki to introduce you to Anna Marie Pyle

You →Akiko · together at Rigimmune →Anna

Sign up to find every way you can get introduced to RNA Connect

  • Your email: who you already know at RNA Connect, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the RNA Connect team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

RNA Connect develops uMRT, a reverse transcriptase enzyme for end-to-end cDNA synthesis that copies full RNA transcripts, including large viral genomes, in a single pass. The technology is aimed at gene expression, regulation, and discovery research applications in the life sciences.

Founders & leadership

AP
Anna PyleFounderAnna Pyle leads research on RNA structure and function, with expertise in viral RNAs, splicing mechanisms, and the protein interactions that govern RNA recognition and processing. Her group employs biophysical and structural methods including crystallography and enzymology to study RNA-binding proteins and RNA-activated motor proteins.
LG
Li-Tao GuoCo-founder & VP of Research and Development
RMRyan Muldoon
Ryan MuldoonCEO

Investors · 1

Related companies · 3

Companies working in the same space as RNA Connect.

Frequently asked questions

What does RNA Connect do?
RNA Connect develops uMRT, a reverse transcriptase enzyme for end-to-end cDNA synthesis that copies full RNA transcripts, including large viral genomes, in a single pass. The technology is aimed at gene expression, regulation, and discovery research applications in the life sciences.
Who founded RNA Connect?
RNA Connect was founded by Anna Pyle, Li-Tao Guo.
Who are RNA Connect's investors?
RNA Connect's investors include Connecticut Innovations.